WebOpportunistic infections pose a significant problem in patients receiving immunosuppressive therapy for autoimmune diseases. We present a case of a woman … Web13. apr 2024 · Polymyositis is a slowly progressing condition and occurs in older age groups. The symptoms can vary from mild to severe. The diagnostic sign of polymyositis …
Tocilizumab in the Treatment of Refractory Polymyositis
WebPolymyositis (PM) and Dermatomyositis (DM) can have heterogeneous clinical presentations but with a limited number of effective drugs making its treatment a … WebCancer-associated myositis occurs most frequently for patients with dermatomyositis. (It has been estimated that as much as 20-30% of DM patients will develop cancer.) Those … termilab
Polymyositis and Dermatomyositis - Rheumatology - Diseases
Web12. apr 2024 · Zurück zum Zitat Mok CC, Ho LY, To CH (2007) Rituximab for refractory polymyositis: an open-label prospective study. J Rheumatol 34:1864–1868 PubMed Mok CC, Ho LY, To CH (2007) Rituximab for refractory polymyositis: an open-label prospective study. Web7. feb 2024 · Dermatomyositis (DM) and polymyositis (PM) are classified as idiopathic inflammatory myopathies. Defining the optimal treatment regimens for these disorders has been difficult because of the rarity of these disorders, their highly complex clinical phenotypes, and the limited number of randomized, double-blind clinical trials [ 1-3 ]. Web7. feb 2024 · Methods: Adults with refractory polymyositis (PM) and adults and children with refractory dermatomyositis (DM) were enrolled. Entry criteria included muscle … termimesh adelaide